Home
OverviewAbout10 LeapsCollaborationImpact
OverviewLeaps TalksChapter FilmsLeaps.orgPartners
AgricultureHealth
OverviewAnnual ReviewBreakthrough StudyPress ReleasesIn the NewsReportsLeaps LeadershipPress KitMedia Contact
Team
  • Approach
    • Overview
    • About
    • 10 Leaps
    • Collaboration
    • Impact
  • Engagement
    • Overview
    • Leaps Talks
    • Chapter Films
    • Leaps.org
    • Partners
    • Agriculture
    • Health
  • News
    • Overview
    • Annual Review
    • Breakthrough Study
    • Press Releases
    • In the News
    • Reports
    • Leaps Leadership
    • Press Kit
    • Media Contact
  • Team
ContactImprintPrivacy StatementConditions of Use
sign up for our newsletter

Breaking through impossible


We invest in teams pursuing fundamental breakthroughs in life science, 
targeting ten huge challenges facing humanity. Some call them impossible. 
We call them "Leaps."

Breaking through impossible

Leaps by the numbers


  • 15+

    New investments and follow-on investments 2023

  • 1.9+ Billion USD

    Total amount invested in Leaps portfolio 2015 - 2023

  • 60+

    # of portfolio companies 2015 - 2023

About


Leaps is the strategic impact investment unit of Bayer. By accelerating transformative biotechnologies, we aim to shift key paradigms in life science, changing the world for better.

In health, we pursue breakthroughs that could set new standards in medical care, moving from treating symptoms to curing or preventing diseases. In agriculture, we drive innovations that could nourish a growing population while restoring the planet.

10 Leaps


Our ten Leaps are at the core of our investment approach. They reflect our ambition to tackle the biggest challenges, with consideration for how Bayer’s 150 years of history and expertise can most make a difference.

Growing knowledge through collaboration


Leaps by Bayer supports early-stage companies and forms new ventures. Significant and sustained investment maximizes their probability of success and enables them to focus on the long-term delivery of their disruptive technology, rather than short-term and lower impact results.

Our portfolio companies remain autonomous with respect to decision making. We support them through what we call “active incubation”. Experienced team members actively engage in the young companies’ development by providing resources and helping them to steer the initial strategic direction.

Impact


How much wellbeing for humanity could we create by e.g., resolving Parkinson’s disease? Or ensuring crop shortages are less severe?

We seek to predict and measure our impact investment approach by developing a new metric of success beyond ROI.

Together with the Happiness Research Institute, we introduced Wellbeing Adjusted Life Years (WALY), a metric determining the impact events have on wellbeing, which also allows to predict how much good for humanity we could generate by addressing disease and solving global issues.

  • Thumbnail

    Learn about our custom impact measurement framework WALY and read about the impact magnitude of our portfolio.

    Download
  • Taking 10 leaps for humanity thumbnail

    See how our 10 Leaps framework could generate return for humanity

    Download
  • Happiness Research PDF Thumbnail

    Read about the work with our partners at the Happiness Research Institute

    Download

Return for Humanity - Impact Videos


We created two videos that further explain our WALY framework. 

Ethical questions need a platform

Biotech breakthroughs raise important ethical questions that can’t be answered by scientists and investors alone. It is our responsibility to engage society in critical discussions.

EXPLORE OUR ENGAGEMENT

01 / Cure genetic diseases

Stopping genetic diseases before they progress could prevent chronic suffering and give each of us the chance to live a full and healthy life.

Explore leap 01

02 / Provide sustainable organ and tissue replacement

Cell and gene therapies hold tremendous promise to restore health, reverse the course of degenerative diseases and prevent organ failure.

Explore leap 02

03 / Reduce environmental impact of agriculture

From carbon sequestration to reducing land and water usage, innovation has the power to transform modern agriculture.

Explore leap 03

04 / Prevent and cure cancer

Biotechnology that leverages the immune system and other emerging platforms could make huge strides in the fight against cancer.

Explore leap 04

05 / Protect brain and mind

Neurodevelopmental and neurodegenerative disease along with mental health disorders represent a massive and growing unmet need with no simple solutions available.

Explore leap 05

06 / Reverse autoimmune diseases and chronic inflammation

Systematically addressing autoimmune diseases and chronic inflammation could enable lives free of pain, disease management, and life-threatening conditions.

Explore leap 06

07 / Provide next generation healthy crops

The Green Revolution lifted millions out of starvation, yet new approaches are needed to provide comprehensive nutrition at a global scale.

Explore leap 07

08 / Develop sustainable protein supply

Nourishing a global population will require new approaches to sustain both a healthy planet and healthy people.

Explore leap 08

09 / Prevent crop and food loss

A pandemic, climate volatility, and an increasingly long and complex supply chain expose the fragility of our global food system and the need for resilience.

Explore leap 09

10 / Transform health with data

From wearable devices to artificial intelligence to protein modeling, digital technology is sparking a revolution in medicine.

Explore leap 10

01 / A Framework for Human & Planetary Wellbeing.

How do you measure real impact beyond financial return? Together with The Happiness Research Institute, we created WALY. A new way to measure what really matters.

02 / How to Measure Impact Investments Beyond Profit

Dive into our methodology with this WALY explainer video: A new lens on impact, grounded in human and planetary wellbeing.